Print

RV 132

Phase I/II Trial of Pasteur-Merieux-Connaught Live Recombinant ALVAC-HIV (vCP1521) with Either Oligomeric gp160 TH023/LAI-DID (Aventis Pasteur) or Chiron's HIV Thai E (CM235) gp120 plus SF2 gp120 in Thai HIV-Seronegative Adults

Trial Details:

I/II Completed
Walter Reed Army Institute of Research (WRAIR), March 01, 2000
ALVAC-HIV vCP1521,gp160 THO23/LAI-DID,rgp120/HIV-1 SF-2
ALVAC-HIV vCP1521 Viral Vector - Pox
gp160 THO23/LAI-DID Protein
rgp120/HIV-1 SF-2 Protein
Thailand 120
http://www.aventispasteur.com